Early Hip Fracture Surgery Safe in Patients on DOACs - Summary - MDSpire

Early Hip Fracture Surgery Safe in Patients on DOACs

  • By

  • Julie Greenbaum

  • February 27, 2026

  • 4 min

Share

Objective:

To evaluate the safety and outcomes of early hip fracture surgery in patients taking direct oral anticoagulants (DOACs).

Key Findings:
  • Median hemoglobin decrease was 0.6 mmol/L in early surgery vs 0.9 mmol/L in delayed surgery.
  • Early surgery was associated with a 0.25 mmol/L lower hemoglobin decrease compared to delayed surgery.
  • No significant differences in blood transfusions or postoperative anemia between the two groups.
  • Early surgery resulted in a shorter median hospital stay (6 days vs 8 days).
  • In-hospital mortality was 1% for early surgery vs 2% for delayed surgery; 30-day mortality was 3% vs 5%.
Interpretation:

Early surgery in patients on DOACs does not lead to greater hemoglobin decrease and is linked to shorter hospital stays, indicating its safety.

Limitations:
  • Retrospective design may introduce bias.
  • Lack of data on timing of last DOAC dose and serum levels.
  • Missing data on comorbidities, fracture type, and functional status.
Conclusion:

Surgery within 24 hours for hip fracture patients on DOACs is safe and does not increase the risk of significant hemoglobin decrease.

Original Source(s)

Related Content